Stefan Kappe Leads Center for Vaccine Development & Global Health
- The internationally recognized malaria researcher will assume his role as director of the school of Medicine's Center for Vaccine Development and Global Health early next year.
- University of Maryland School of Medicine (UMSOM) Dean Mark T.
- Kappe is currently a professor and the associate vice chair of basic science research in the Department of Pediatrics at the University of Washington in Seattle.
“`html
Stefan Kappe to Lead Center for Vaccine Growth and Global Health
Table of Contents
Deborah Kotz
The internationally recognized malaria researcher will assume his role as director of the school of Medicine’s Center for Vaccine Development and Global Health early next year.
Appointment Details
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced Sept. 9 the appointment of distinguished parasitologist and immunologist Stefan Kappe, PhD, to be the new director of the school’s Center for Vaccine Development and Global Health (CVD). He will also serve as the Myron M. Levine, MD, DTPH Professor of Vaccinology in the Department of pediatrics.
Kappe is currently a professor and the associate vice chair of basic science research in the Department of Pediatrics at the University of Washington in Seattle. He is also a senior principal investigator at the Center for Global infectious disease Research at Seattle Children’s Research Institute, where he recently served as an associate director. Dr. kappe is internationally known for his transformational work in genetic engineering of parasites, which has led to a novel malaria vaccine type that demonstrated the potential to provide a high level of protection against malaria infection in preclinical models and a clinical study. He is also recognized for his landmark research on the early phases of malaria parasite infection in the liver.
He plans to begin his new position early next year; James Campbell, MD, MS, professor of pediatrics at UMSOM, will continue to serve as interim director of CVD until that time. He took over in July from Miriam laufer,MD,who had been serving as interim director since April 2024.
Kappe’s Research Focus
Kappe’s laboratory focuses on understanding the complex pathobiology of malaria parasites and immune responses to infection,with the goal of designing transformational interventions.